Calidi Biotherapeutics, Inc. (CLDI)

Latest Insider Confidence Score

2025Q4

62.0
Bullish

Company insider confidence (by quarter)

2024Q3 2025Q4

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Lincoln Alternative Strategies LLC 730,000 Aug 27, 2025
Leftwich Scott Director 67,774 Jan 3, 2025
Camaisa Allan CEO 66,712 Dec 18, 2024
Stewart Alan R. 28,976 Jan 3, 2025
Poma Eric E CEO 25,000 Aug 25, 2025

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 3, 2025 Sep 5, 2025 Poma Eric E CEO Neutral 52.5 - 0.00% -
Sep 3, 2025 Sep 5, 2025 Fernandez Santidrian Antonio Chief Scientific Officer Neutral 52.5 - 0.00% -
Sep 3, 2025 Sep 5, 2025 Jackson Andrew C. CFO Neutral 52.5 - 0.00% -
Aug 27, 2025 Lincoln Alternative Strategies LLC 10% Owner Neutral 52.5 - 0.00% -
Aug 21, 2025 Aug 25, 2025 Schoeneck James A Director Buy 95.0 +75,000 788.31% $150K
Aug 21, 2025 Aug 25, 2025 Poma Eric E CEO Buy 95.0 +25,000 100.00% $50K
Aug 21, 2025 Aug 25, 2025 Leftwich Scott Director Buy 97.5 +125,000 577.87% $250K
Aug 21, 2025 Aug 25, 2025 Jackson Andrew C. CFO Buy 90.0 +2,500 100.00% $5K
Jul 9, 2025 Jul 15, 2025 Schoeneck James A Director Neutral 52.5 - 0.00% -
Jul 9, 2025 Jul 15, 2025 Stewart Alan R. Director Neutral 52.5 - 0.00% -
Jul 9, 2025 Jul 15, 2025 Peoples George Director Neutral 52.5 - 0.00% -
Jul 9, 2025 Jul 15, 2025 Leftwich Scott Director Neutral 52.5 - 0.00% -
Apr 22, 2025 Apr 25, 2025 Poma Eric E CEO Neutral 52.5 - 0.00% -
Apr 25, 2025 Poma Eric E CEO Neutral 52.5 - 0.00% -
Dec 31, 2024 Jan 3, 2025 Stewart Alan R. Director Neutral 90.0 +12,771 78.81% -
Dec 31, 2024 Jan 3, 2025 Leftwich Scott Director Neutral 90.0 +11,684 20.83% -
Dec 17, 2024 Dec 18, 2024 Camaisa Allan CEO Sell 26.3 -10,000 -13.04% $16.2K
Sep 20, 2024 Oct 15, 2024 Leftwich Scott Director Neutral 52.5 - 0.00% -
Sep 20, 2024 Oct 15, 2024 Peoples George Director Neutral 52.5 - 0.00% -
Sep 20, 2024 Oct 15, 2024 Schoeneck James A Director Neutral 52.5 - 0.00% -
Sep 20, 2024 Oct 15, 2024 Stewart Alan R. Director Neutral 52.5 - 0.00% -
Sep 26, 2024 Sep 30, 2024 Camaisa Allan CEO Neutral 90.0 +70,155 1069.93% -